Wendel S, Dayawansa T, Das P C, Smit Sibinga C T
Blood Bank, Hospital Sirio Libanes, Sao Paulo, Brasil.
Int J Artif Organs. 1990 Apr;13(4):247-53.
Autologous bone marrow (BM) transplantation is being increasingly applied in hematological and oncological patients. However, because of the need to purify and preserve BM requiring high technology, such treatments are virtually concentrated in the "developed" countries. This paper examines methods of BM purification and freezing that could make the technique potentially applicable in developing countries. Hemapheresis is routinely applied for BM purification in our Dutch Centre, where the buffy coats obtained from routine blood donations were utilised in experimental settings. Using DMSO as cryoprotectant, semi-purified white cells were frozen in liquid N2 (LN2), by mechanical freezer or snap-frozen at -55 degrees C. Different types of containers were compared including plastic tubes and ordinary blood bags. After thawing the results show that snap-freezing had a deleterious effect but the cell yields and viability were similar in LN2 or the mechanical freezer where the tubes and the bag were equally effective as containers (86% cell recovery with 90% viability). In the purification/concentration stage, reduction of the volume of the material by extra centrifugation, thus requiring less DMSO, produced better results--96% cell yield and 90% viability after thawing. This simplified method was applied in a general hospital in Sao Paulo where four oncology patients underwent BM collection. BM was purified and concentrated within a blood bank facility. Hydroxyethyl starch sedimentation and centrifugation of the material in plastic blood bags gave 80% BM cell harvest. After thawing from the mechanical freezer 1 x 10(8) BM cells/kg were available for reinfusion to patients. There was no immediate untoward reaction. Three of the patients showed signs of bone marrow regeneration by three weeks, but one patient died 16 days after transplantation, of septicemia. We conclude that certain high-technology procedures for ABMT can be adapted for existing facilities in developing countries.
自体骨髓移植正越来越多地应用于血液学和肿瘤学患者。然而,由于需要高技术来纯化和保存骨髓,此类治疗实际上集中在“发达”国家。本文研究了骨髓纯化和冷冻方法,以使该技术有可能应用于发展中国家。在我们荷兰的中心,血液成分单采术被常规用于骨髓纯化,从常规献血中获得的血沉棕黄层被用于实验。使用二甲亚砜作为冷冻保护剂,半纯化的白细胞通过机械冷冻机在液氮中冷冻,或在-55℃下速冻。比较了不同类型的容器,包括塑料管和普通血袋。解冻后的结果显示,速冻有有害影响,但在液氮或机械冷冻机中细胞产量和活力相似,其中管子和袋子作为容器同样有效(细胞回收率86%,活力90%)。在纯化/浓缩阶段,通过额外离心减少材料体积,从而需要较少的二甲亚砜,产生了更好的结果——解冻后细胞产量96%,活力90%。这种简化方法应用于圣保罗的一家综合医院,四名肿瘤患者接受了骨髓采集。骨髓在血库设施内进行纯化和浓缩。在塑料血袋中对材料进行羟乙基淀粉沉降和离心,获得了80%的骨髓细胞收获率。从机械冷冻机解冻后,有1×10⁸个骨髓细胞/千克可用于回输给患者。没有立即出现不良反应。三名患者在三周时显示出骨髓再生的迹象,但一名患者在移植后16天死于败血症。我们得出结论,某些高技术的自体骨髓移植程序可以适用于发展中国家现有的设施。